scholarly article | Q13442814 |
P50 | author | Francis Collins | Q336658 |
P2093 | author name string | Pachiappan Manickam | |
Bruce A. Roe | |||
Yingping Wang | |||
Young S. Kim | |||
Lance A. Liotta | |||
Allen M. Spiegel | |||
Jane M. Weisemann | |||
Judy S. Crabtree | |||
Lee Burns | |||
Mark S. Boguski | |||
Mary Beth Kester | |||
Michael R. Emmert-Buck | |||
Settara C. Chandrasekharappa | |||
Shodimu-Emmanuel Olufemi | |||
Siradanahalli C. Guru | |||
Stephen J. Marx | |||
Sunita K. Agarwal | |||
P2860 | cites work | Four genes for the calpain family locate on four distinct human chromosomes | Q24297648 |
Differential expression of a novel protein kinase in human B lymphocytes. Preferential localization in the germinal center | Q24305514 | ||
MLK-3: identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain | Q24314246 | ||
The human NFKB3 gene encoding the p65 subunit of transcription factor NF-kappa B is located on chromosome 11q12 | Q24314931 | ||
The role of the 70 kDa subunit of human DNA polymerase alpha in DNA replication | Q24317744 | ||
Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1) | Q24319691 | ||
Cloning and characterization of SOX5, a new member of the human SOX gene family | Q24336163 | ||
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors | Q24558744 | ||
Selective amplification of additional members of the ADP-ribosylation factor (ARF) family: cloning of additional human and Drosophila ARF-like genes | Q24561414 | ||
Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13 | Q28207877 | ||
A genome-wide search for human type 1 diabetes susceptibility genes | Q28247197 | ||
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1 | Q28257084 | ||
Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator | Q28276496 | ||
Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12 | Q28290240 | ||
Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13 | Q28291977 | ||
Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1) | Q28297875 | ||
The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumours | Q28306877 | ||
Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 | ||
Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. | Q34319769 | ||
A radiation hybrid map of 506 STS markers spanning human chromosome 11. | Q34327393 | ||
Assignment of the human FAU gene to a subregion of chromosome 11q13. | Q34357941 | ||
Cloning and characterization of a novel human gene related to vascular endothelial growth factor | Q34407476 | ||
PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation | Q35020643 | ||
Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. | Q35248378 | ||
Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland | Q35889219 | ||
The complete nucleotide sequences of the SacBII Kan domain of the P1 pAD10-SacBII cloning vector and three cosmid cloning vectors: pTCF, svPHEP, and LAWRIST16. | Q36699558 | ||
Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene | Q36800237 | ||
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors | Q38474599 | ||
Isolation, cDNA, and genomic structure of a conserved gene (NOF) at chromosome 11q13 next to FAU and oriented in the opposite transcriptional orientation | Q42637479 | ||
Allelic loss from chromosome 11 in parathyroid tumors | Q43873367 | ||
Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region | Q48041395 | ||
A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13. | Q48048567 | ||
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
Bardet-Biedl syndrome is linked to DNA markers on chromosome 11q and is genetically heterogeneous. | Q52026513 | ||
Exclusion of the phosphoinositide-specific phospholipase C?3 ( PLCB3 ) gene as a candidate for multiple endocrine neoplasia type 1 | Q57423377 | ||
Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1 | Q57423385 | ||
Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13 | Q57785288 | ||
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996 | Q58298544 | ||
Exclusion of FAU as the Multiple Endocrine Neoplasia type 1 (MEN1) gene | Q58862224 | ||
Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1 | Q61964010 | ||
Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations | Q68170270 | ||
Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q | Q70457420 | ||
Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant | Q71739592 | ||
Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers | Q71739620 | ||
Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients | Q71767618 | ||
Exclusion of the phosphatidylinositol-specific phospholipase C beta 3 (PLC beta 3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene | Q72997882 | ||
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene | Q73148757 | ||
Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1 | Q73320115 | ||
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis | Q73352853 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
multiple endocrine neoplasia type 1 | Q3347154 | ||
P304 | page(s) | 725-35 | |
725-735 | |||
P577 | publication date | 1997-07-01 | |
P1433 | published in | Genome Research | Q5533485 |
P1476 | title | A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus | |
A Transcript Map for the 2.8-Mb Region Containing the Multiple Endocrine Neoplasia Type 1 Locus | |||
P478 | volume | 7 |
Q64117174 | /miR-15b-5p/ mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway |
Q21266548 | A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains |
Q24298381 | Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles |
Q37577411 | COME: a robust coding potential calculation tool for lncRNA identification and characterization based on multiple features |
Q46179887 | Cellular, physiological and pathological aspects of the long non-coding RNA NEAT1. |
Q37180408 | Circadian RNA expression elicited by 3'-UTR IRAlu-paraspeckle associated elements. |
Q37058787 | Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors |
Q24675000 | Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation |
Q34175646 | Competition between a noncoding exon and introns: Gomafu contains tandem UACUAAC repeats and associates with splicing factor-1. |
Q22254234 | Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints |
Q61829458 | DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation |
Q22253181 | EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins |
Q28138049 | Evaluation and molecular characterization of EHD1, a candidate gene for Bardet-Biedl syndrome 1 (BBS1) |
Q30733169 | Expression and characterisation of a Plasmodium falciparum protein containing domains homologous to sarcalumenin and a tyrosine kinase substrate, eps15. |
Q30961562 | Expression of calcium-binding protein S100A2 in breast lesions |
Q37028376 | Functions of long noncoding RNAs in the nucleus |
Q35908958 | Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. |
Q35914857 | Genome-wide analysis of long noncoding RNA stability |
Q28277773 | Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1) |
Q37309402 | How to build a paraspeckle |
Q42070258 | Hypoxic regulation of the noncoding genome and NEAT1. |
Q24290535 | Identification and characterization of SNX15, a novel sorting nexin involved in protein trafficking |
Q28277763 | Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene |
Q24321851 | Identification and molecular characterization of TM7SF2 in the FAUNA gene cluster on human chromosome 11q13 |
Q40858956 | Interstitial deletion of 11q13 sequences in HeLa cells |
Q60921039 | Involvement of the long noncoding RNA NEAT1 in carcinogenesis |
Q41340504 | Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis |
Q38776920 | Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer |
Q38928694 | Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells |
Q38846361 | Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis |
Q38716426 | Long noncoding RNAs as Organizers of Nuclear Architecture |
Q29620125 | MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer |
Q34517905 | MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. |
Q24651886 | MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles |
Q73595299 | MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma |
Q24646100 | MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles |
Q36143068 | Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors |
Q24310070 | Menin, the product of the MEN1 gene, is a nuclear protein |
Q37382561 | NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis |
Q26865214 | Paraspeckle formation during the biogenesis of long non-coding RNAs |
Q36192065 | Paraspeckle nuclear bodies--useful uselessness? |
Q28591342 | Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice |
Q47165921 | Paraspeckles as rhythmic nuclear mRNA anchorages responsible for circadian gene expression |
Q39365927 | Roles of LncRNAs in Viral Infections |
Q49277303 | Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs |
Q40918854 | Stable overexpression of MEN1 suppresses tumorigenicity of RAS. |
Q24338184 | The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene |
Q64276928 | The Implications of the Long Non-Coding RNA in Non-Cancerous Diseases |
Q42376160 | The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis |
Q47814736 | The future: genetics advances in MEN1 therapeutic approaches and management strategies. |
Q33697479 | The gene for multiple endocrine neoplasia type 1: recent findings. |
Q47632021 | The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis. |
Q37060040 | The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis |
Q33963677 | The reality of pervasive transcription |
Q35602321 | Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. |
Q36250659 | Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis |
Search more.